Author(s): Ik M, Kl L, Doan , Calgneri M
Abstract Share this page
Abstract Giant cell arteritis (GCA), previously Horton's disease, is a systemic vasculitis affecting the middle-sized or large arteries in patients older than 50 years of age. The mainstay of the treatment of GCA is glucocorticoid therapy. Herein, we present a case with giant cell arteritis resistant to oral and intravenous steroid, intravenous cyclophosphamide and mycophenolate mofetil, but successfully treated with tocilizumab.
This article was published in Rheumatol Int
and referenced in Journal of Arthritis